{"schema_version":"1","generated_at":"2026-10-29T13:44:09.033Z","data_as_of":null,"url":"https://www.findmykol.com/kol/eric-winer-ma","json_url":"https://www.findmykol.com/kol/eric-winer-ma/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"eric-winer-ma","name":"Eric Winer","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1609852516"},"summary":"Eric Winer is an Oncology physician. ClinicalTrials.gov lists 8 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":8,"shown":3,"withheld":2,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT03735446","title":"Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial","phase":"PHASE1","status":"TERMINATED","role":"Overall official","sponsor":"Dana-Farber Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT03735446","trial_url":"https://www.findmykol.com/trial/NCT03735446"},{"nct":"NCT01629615","title":"A Trial of BKM120 (a PI3K Inhibitor) in Patients With Triple Negative Metastatic Breast Cancer","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"SOLTI Breast Cancer Research Group","source_url":"https://clinicaltrials.gov/study/NCT01629615","trial_url":"https://www.findmykol.com/trial/NCT01629615"},{"nct":"NCT00148681","title":"Preoperative Herceptin and Navelbine for Breast Cancer","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"Dana-Farber Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT00148681","trial_url":"https://www.findmykol.com/trial/NCT00148681"}],"source":"trials"},"payments":{"company_count":6,"program_years":{"first":2021,"last":null},"rows_total":6,"shown":3,"withheld":3,"rows":[{"payer":"Syndax Pharmaceuticals, Inc.","program_year":2025,"amount_usd":4633.47,"payment_count":8,"source_url":"https://openpaymentsdata.cms.gov/search?query=1609852516"},{"payer":"Geron Corporation","program_year":2025,"amount_usd":104.14,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1609852516"},{"payer":"Rigel Pharmaceuticals, Inc.","program_year":2024,"amount_usd":3974.55,"payment_count":9,"source_url":"https://openpaymentsdata.cms.gov/search?query=1609852516"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1609852516","source":"payments"},"funding":{"award_count":4,"fiscal_years":{"first":2000,"last":2023},"rows_total":59,"shown":3,"withheld":56,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"P50CA168504","title":"Project 1 - Overcoming Breast Cancer Resistance to CDK4/6 Inhibition","fiscal_year":2023,"amount_usd":"359023","organization":"DANA-FARBER CANCER INST","source_url":"https://reporter.nih.gov/quickSearch/P50CA168504"},{"project":"P30CA006516","title":"Program 01 Breast Cancer","fiscal_year":2023,"amount_usd":"42854","organization":"DANA-FARBER CANCER INST","source_url":"https://reporter.nih.gov/quickSearch/P30CA006516"},{"project":"P50CA168504","title":"Core A: Administrative","fiscal_year":2022,"amount_usd":"191842","organization":"DANA-FARBER CANCER INST","source_url":"https://reporter.nih.gov/quickSearch/P50CA168504"}],"source":"grants"},"contact":{"address_1":"450 BROOKLINE AVE","city":"Boston","state":"MA","zip":"022155418","phone":"617-632-2053","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1609852516","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":2,"payments":3,"funding":56}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2017-03-16","collected_at":"2026-10-27T00:00:00.000Z"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}